{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,15]],"date-time":"2025-12-15T19:31:53Z","timestamp":1765827113445},"reference-count":56,"publisher":"Public Library of Science (PLoS)","issue":"8","license":[{"start":{"date-parts":[[2013,8,29]],"date-time":"2013-08-29T00:00:00Z","timestamp":1377734400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.ploscompbiol.org"],"crossmark-restriction":false},"short-container-title":["PLoS Comput Biol"],"DOI":"10.1371\/journal.pcbi.1003203","type":"journal-article","created":{"date-parts":[[2013,8,29]],"date-time":"2013-08-29T22:09:18Z","timestamp":1377814158000},"page":"e1003203","update-policy":"http:\/\/dx.doi.org\/10.1371\/journal.pcbi.corrections_policy","source":"Crossref","is-referenced-by-count":21,"title":["The Individualized Genetic Barrier Predicts Treatment Response in a Large Cohort of HIV-1 Infected Patients"],"prefix":"10.1371","volume":"9","author":[{"given":"Niko","family":"Beerenwinkel","sequence":"first","affiliation":[]},{"given":"Hesam","family":"Montazeri","sequence":"additional","affiliation":[]},{"given":"Heike","family":"Schuhmacher","sequence":"additional","affiliation":[]},{"given":"Patrick","family":"Knupfer","sequence":"additional","affiliation":[]},{"given":"Viktor","family":"von Wyl","sequence":"additional","affiliation":[]},{"given":"Hansjakob","family":"Furrer","sequence":"additional","affiliation":[]},{"given":"Manuel","family":"Battegay","sequence":"additional","affiliation":[]},{"given":"Bernard","family":"Hirschel","sequence":"additional","affiliation":[]},{"given":"Matthias","family":"Cavassini","sequence":"additional","affiliation":[]},{"given":"Pietro","family":"Vernazza","sequence":"additional","affiliation":[]},{"given":"Enos","family":"Bernasconi","sequence":"additional","affiliation":[]},{"given":"Sabine","family":"Yerly","sequence":"additional","affiliation":[]},{"given":"J\u00fcrg","family":"B\u00f6ni","sequence":"additional","affiliation":[]},{"given":"Thomas","family":"Klimkait","sequence":"additional","affiliation":[]},{"given":"Cristina","family":"Cellerai","sequence":"additional","affiliation":[]},{"given":"Huldrych F.","family":"G\u00fcnthard","sequence":"additional","affiliation":[]},{"name":"The Swiss HIV Cohort Study","sequence":"additional","affiliation":[]}],"member":"340","published-online":{"date-parts":[[2013,8,29]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1001\/jama.2010.1004","article-title":"Antiretroviral treatment of adult HIV infection: 2010 recommendations of the international AIDS Society-USA panel","volume":"304","author":"MA Thompson","year":"2010","journal-title":"JAMA"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1086\/589297","article-title":"Antiretroviral drug resistance testing in adult HIV-1 infection: 2008 recommendations of an international AIDS Society-USA panel","volume":"47","author":"MS Hirsch","year":"2008","journal-title":"Clin Infect Dis"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"Article 6","DOI":"10.2202\/1544-6115.1604","article-title":"Learning from past treatments and their outcome improves prediction of in vivo response to anti-HIV therapy","volume":"10","author":"H Saigo","year":"2011","journal-title":"Stat Appl Genet Mol Biol"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1186\/1742-6405-8-26","article-title":"HIV-1 mutational pathways under multidrug therapy","volume":"8","author":"G Lawyer","year":"2011","journal-title":"AIDS Res Ther"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1086\/378355","article-title":"Assessing resistance costs of antiretroviral therapies via measures of future drug options","volume":"188","author":"H Jiang","year":"2003","journal-title":"J Infect Dis"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"2093","DOI":"10.1002\/sim.1155","article-title":"Modelling HIV viral rebound using non-linear mixed effects models","volume":"21","author":"AP Fitzgerald","year":"2002","journal-title":"Stat Med"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1186\/1472-6947-11-40","article-title":"A prognostic model for estimating the time to virologic failure in HIV-1 infected patients undergoing a new combination antiretroviral therapy regimen","volume":"11","author":"MCF Prosperi","year":"2011","journal-title":"BMC Med Inform Decis Mak"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1086\/376512","article-title":"Comparison between rules-based human immunodeficiency virus type 1 genotype interpretations and real or virtual phenotype: concordance analysis and correlation with clinical outcome in heavily treated patients","volume":"188","author":"C Torti","year":"2003","journal-title":"J Infect Dis"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1177\/135965350000500112","article-title":"The relation between baseline HIV drug resistance and response to antiretroviral therapy: re-analysis of retrospective and prospective studies using a standardized data analysis plan","volume":"5","author":"V DeGruttola","year":"2000","journal-title":"Antivir Ther"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1177\/135965350300800512","article-title":"Impact of genotypic resistance testing on selection of salvage regimen in clinical practice","volume":"8","author":"S Haupts","year":"2003","journal-title":"Antivir Ther"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1097\/00002030-200202150-00008","article-title":"Usefulness of monitoring HIV drug resistance and adherence in individuals failing highly active antiretroviral therapy: a randomized study (ARGENTA)","volume":"16","author":"A Cingolani","year":"2002","journal-title":"AIDS"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1097\/00002030-200201250-00010","article-title":"Clinical utility of HIV-1 genotyping and expert advice: the Havana trial","volume":"16","author":"C Tural","year":"2002","journal-title":"AIDS"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1097\/00126334-200303010-00005","article-title":"Real versus virtual phenotype to guide treatment in heavily pretreated patients: 48-week follow-up of the genotipo-fenotipo di resistenza (GenPheRex) trial","volume":"32","author":"F Mazzotta","year":"2003","journal-title":"J Acquir Immune Defic Syndr"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1097\/00002030-200203290-00008","article-title":"Phenotypic or genotypic resistance testing for choosing antiretroviral therapy after treatment failure: a randomized trial","volume":"16","author":"JL Meynard","year":"2002","journal-title":"AIDS"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"i16","DOI":"10.1093\/bioinformatics\/btg1001","article-title":"Methods for optimizing antiviral combination therapies","volume":"19 Suppl 1","author":"N Beerenwinkel","year":"2003","journal-title":"Bioinformatics"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"3943","DOI":"10.1093\/bioinformatics\/bti654","article-title":"Computational methods for the design of effective therapies against drug resistant HIV strains","volume":"21","author":"N Beerenwinkel","year":"2005","journal-title":"Bioinformatics"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1038\/nrmicro1477","article-title":"Bioinformatics-assisted anti-HIV therapy","volume":"4","author":"T Lengauer","year":"2006","journal-title":"Nat Rev Microbiol"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"Article7","DOI":"10.2202\/1544-6115.1240","article-title":"Super learning: an application to the prediction of HIV-1 drug resistance","volume":"6","author":"SE Sinisi","year":"2007","journal-title":"Stat Appl Genet Mol Biol"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1177\/135965350701200112","article-title":"The development of artificial neural networks to predict virological response to combination HIV therapy","volume":"12","author":"B Larder","year":"2007","journal-title":"Antivir Ther"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"e3470","DOI":"10.1371\/journal.pone.0003470","article-title":"Comparison of classifier fusion methods for predicting response to anti HIV-1 therapy","volume":"3","author":"A Altmann","year":"2008","journal-title":"PLoS One"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"i399","DOI":"10.1093\/bioinformatics\/btn141","article-title":"Selecting anti-HIV therapies based on a variety of genomic and clinical factors","volume":"24","author":"M Rosen-Zvi","year":"2008","journal-title":"Bioinformatics"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1093\/bioinformatics\/btn568","article-title":"Stochastic modelling of genotypic drug-resistance for human immunodeficiency virus towards long-term combination therapy optimization","volume":"25","author":"MCF Prosperi","year":"2009","journal-title":"Bioinformatics"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1177\/135965350901400315","article-title":"Investigation of expert rule bases, logistic regression, and non-linear machine learning techniques for predicting response to antiretroviral treatment","volume":"14","author":"MCF Prosperi","year":"2009","journal-title":"Antivir Ther"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"2085","DOI":"10.1093\/bioinformatics\/btq361","article-title":"Dealing with sparse data in predicting outcomes of HIV combination therapies","volume":"26","author":"J Bogojeska","year":"2010","journal-title":"Bioinformatics"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"Article 11","DOI":"10.1515\/1544-6115.1769","article-title":"Hierarchical Bayes model for predicting effectiveness of HIV combination therapies","volume":"11","author":"J Bogojeska","year":"2012","journal-title":"Stat Appl Genet Mol Biol"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1177\/135965350701200202","article-title":"Improved prediction of response to antiretroviral combination therapy using the genetic barrier to drug resistance","volume":"12","author":"A Altmann","year":"2007","journal-title":"Antivir Ther"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1177\/135965350901400201","article-title":"Advantages of predicted phenotypes and statistical learning models in inferring virological response to antiretroviral therapy from HIV genotype","volume":"14","author":"A Altmann","year":"2009","journal-title":"Antivir Ther"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1086\/597305","article-title":"Predicting the response to combination antiretroviral therapy: Retrospective validation of geno2pheno-THEO on a large clinical database","volume":"199","author":"A Altmann","year":"2009","journal-title":"J Infect Dis"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1086\/422692","article-title":"Weighted phenotypic susceptibility scores are predictive of the HIV-1 RNA response in protease inhibitor-experienced HIV-1-infected subjects","volume":"190","author":"R Swanstrom","year":"2004","journal-title":"J Infect Dis"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1086\/600073","article-title":"Predictive value of HIV-1 genotypic resistance test interpretation algorithms","volume":"200","author":"SY Rhee","year":"2009","journal-title":"J Infect Dis"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"e11505","DOI":"10.1371\/journal.pone.0011505","article-title":"Comparison of HIV-1 genotypic resistance test interpretation systems in predicting virological outcomes over time","volume":"5","author":"D Frentz","year":"2010","journal-title":"PLoS One"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1177\/135965350200700206","article-title":"A genotypic drug resistance interpretation algorithm that significantly predicts therapy response in HIV-1-infected patients","volume":"7","author":"K Van Laethem","year":"2002","journal-title":"Antivir Ther"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1093\/jac\/dkp252","article-title":"Rules-based HIV-1 genotypic resistance interpretation systems predict 8 week and 24 week virological antiretroviral treatment outcome and benefit from drug potency weighting","volume":"64","author":"M Zazzi","year":"2009","journal-title":"J Antimicrob Chemother"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"1934","DOI":"10.1086\/375355","article-title":"Variable prediction of antiretroviral treatment outcome by different systems for interpreting genotypic human immunodeficiency virus type 1 drug resistance","volume":"187","author":"A De Luca","year":"2003","journal-title":"J Infect Dis"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1111\/j.1468-1293.2010.00871.x","article-title":"Prediction of response to antiretroviral therapy by human experts and by the EuResist data-driven expert system (the EVE study)","volume":"12","author":"M Zazzi","year":"2011","journal-title":"HIV Med"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1177\/135965350801300316","article-title":"Modelled in vivo HIV fitness under drug selective pressure and estimated genetic barrier towards resistance are predictive for virological response","volume":"13","author":"K Deforche","year":"2008","journal-title":"Antivir Ther"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"1953","DOI":"10.1086\/430005","article-title":"Estimating HIV evolutionary pathways and the genetic barrier to drug resistance","volume":"191","author":"N Beerenwinkel","year":"2005","journal-title":"J Infect Dis"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/S1473-3099(11)70314-0","article-title":"Selection of chronic hepatitis b therapy with high barrier to resistance","volume":"12","author":"R Gish","year":"2012","journal-title":"Lancet Infect Dis"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1016\/j.coviro.2012.08.004","article-title":"The distinct contributions of fitness and genetic barrier to the development of antiviral drug resistance","volume":"2","author":"M G\u00f6tte","year":"2012","journal-title":"Curr Opin Virol"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1186\/1471-2105-11-409","article-title":"Estimating the individualized HIV-1 genetic barrier to resistance using a nelfinavir fitness landscape","volume":"11","author":"K Theys","year":"2010","journal-title":"BMC Bioinformatics"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1093\/bioinformatics\/btm540","article-title":"Estimation of an in vivo fitness landscape experienced by hiv-1 under drug selective pressure useful for prediction of drug resistance evolution during treatment","volume":"24","author":"K Deforche","year":"2008","journal-title":"Bioinformatics"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"1898","DOI":"10.1099\/vir.0.022657-0","article-title":"Resistance pathways of human immunodeficiency virus type 1 against the combination of zidovudine and lamivudine","volume":"91","author":"K Theys","year":"2010","journal-title":"J Gen Virol"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1097\/01.qai.0000209899.05126.e4","article-title":"The calculated genetic barrier for antiretroviral drug resistance substitutions is largely similar for different hiv-1 subtypes","volume":"41","author":"DA van de Vijver","year":"2006","journal-title":"J Acquir Immune Defic Syndr"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"3","DOI":"10.2202\/1544-6115.1603","article-title":"Learning monotonic genotype-phenotype maps","volume":"10","author":"N Beerenwinkel","year":"2011","journal-title":"Stat Appl Genet Mol Biol"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"1782","DOI":"10.1001\/archinte.167.16.1782","article-title":"Emergence of HIV-1 drug resistance in previously untreated patients initiating combination antiretroviral treatment: a comparison of different regimen types","volume":"167","author":"V von Wyl","year":"2007","journal-title":"Arch Intern Med"},{"key":"ref46","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1093\/ije\/dyp321","article-title":"Cohort profile: the Swiss HIV Cohort Study","volume":"39","author":"F Schoeni-Affolter","year":"2010","journal-title":"Int J Epidemiol"},{"key":"ref47","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1001\/jama.2012.7961","article-title":"Antiretroviral treatment of adult HIV infection: 2012 recommendations of the international antiviral Society-USA panel","volume":"308","author":"MA Thompson","year":"2012","journal-title":"JAMA"},{"key":"ref48","doi-asserted-by":"crossref","unstructured":"van der Laan MJ, Rose S (2011) Targeted Learning. Springer.","DOI":"10.1007\/978-1-4419-9782-1"},{"issue":"1","key":"ref49","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1097\/QAI.0b013e318211925e","article-title":"Viral suppression rates in salvage treatment with raltegravir improved with the administration of genotypic partially active or inactive nucleoside\/tide reverse transcriptase inhibitors","volume":"57","author":"AU Scherrer","year":"2011","journal-title":"J Acquir Immune Defic Syndr"},{"key":"ref50","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1177\/135965350801300108","article-title":"Self-reported non-adherence to antiretroviral therapy repeatedly assessed by two questions predicts treatment failure in virologically suppressed patients","volume":"13","author":"TR Glass","year":"2008","journal-title":"Antivir Ther"},{"key":"ref51","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1097\/QAI.0b013e3181ca48bf","article-title":"Longitudinal analysis of patterns and predictors of changes in self-reported adherence to antiretroviral therapy: Swiss HIV Cohort Study","volume":"54","author":"TR Glass","year":"2010","journal-title":"J Acquir Immune Defic Syndr"},{"key":"ref52","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1093\/nar\/gkg100","article-title":"Human immunodeficiency virus reverse transcriptase and protease sequence database","volume":"31","author":"SY Rhee","year":"2003","journal-title":"Nucleic Acids Res"},{"key":"ref53","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1111\/j.2517-6161.1996.tb02080.x","article-title":"Regression shrinkage and selection via the lasso","volume":"58","author":"R Tibshirani","year":"1996","journal-title":"J Roy Stat Soc B"},{"key":"ref54","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1093\/bioinformatics\/btk011","article-title":"Accurate prediction of HIV-1 drug response from the reverse transcriptase and protease amino acid sequences using sparse models created by convex optimization","volume":"22","author":"M Rabinowitz","year":"2006","journal-title":"Bioinformatics"},{"key":"ref55","first-page":"301320","article-title":"Regularization and variable selection via the elastic net","volume":"67, Part 2","author":"H Zou","year":"2005","journal-title":"J R Statist Soc B"},{"key":"ref56","doi-asserted-by":"crossref","unstructured":"Hastie T, Tibshirani R, Friedman J (2009) The Elements of Statistical Learning, 2nd edition. Springer.","DOI":"10.1007\/978-0-387-84858-7"}],"container-title":["PLoS Computational Biology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pcbi.1003203","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,17]],"date-time":"2024-05-17T12:50:03Z","timestamp":1715950203000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pcbi.1003203"}},"subtitle":[],"editor":[{"given":"Anne-Mieke","family":"Vandamme","sequence":"first","affiliation":[]}],"short-title":[],"issued":{"date-parts":[[2013,8,29]]},"references-count":56,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2013,8,29]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pcbi.1003203","relation":{},"ISSN":["1553-7358"],"issn-type":[{"type":"electronic","value":"1553-7358"}],"subject":[],"published":{"date-parts":[[2013,8,29]]}}}